Search results

From Self-sufficiency
Jump to: navigation, search
  • | title=Slowing disease's mental ravages ...and increase [[complex IV]], whose inhibition correlates with Alzheimer's disease.
    27 KB (3,650 words) - 16:46, 27 September 2010
  • ...in a study doses of valproic acid reversed the early stages of Alzheimer's disease in mice. Human trials are underway.{{Citation needed|date=June 2010}} ...me patients with symptomatic but manageable AIDS, cancer, hepatic or renal disease are kept on the medication (usually at a reduced dose with more frequent bl
    25 KB (3,328 words) - 16:47, 27 September 2010
  • ...olemia]] (elevated [[cholesterol]] levels) and to prevent [[cardiovascular disease]]. Simvastatin is a synthetic derivate of a fermentation product of ''[[As ...astatin is associated with a reduced incidence of dementia and Parkinson's disease | journal =BMC Medicine | volume =5 | pages =20 | date =July 19, 2007 | doi
    14 KB (1,967 words) - 16:48, 27 September 2010
  • ...of dopamine in the brains of patients with diseases such as [[Parkinson's disease]] and dopa-responsive [[dystonia]], [[L-DOPA]], which is the precursor of d ..." Movement Disorder Society’s 10th International Congress of Parkinson's Disease and Movement Disorders on November 1, 2006, in Kyoto, Japan.]</ref> It was
    48 KB (6,470 words) - 16:48, 27 September 2010
  • ...is also used in [[gastro-esophageal reflux disease|gastroesophageal reflux disease (GERD/GORD)]]. ...in [[phaeochromocytoma]]. It should be used with caution in [[Parkinson's disease]] since, as a dopamine antagonist, it may worsen symptoms. Long-term use sh
    11 KB (1,453 words) - 16:49, 27 September 2010
  • ...send KP, Praticò D |title=Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs |journal=FASEB J. |volume=19 ...|title=Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease |journal=Ann Neurol |volume=58 |issue=6 |pages=963–7 |year=2005 |pmid=162
    29 KB (3,955 words) - 22:17, 21 September 2010
  • ...], [[alcohol withdrawal]], [[benzodiazepine withdrawal]] and [[Ménière's disease]]. It may also be used before certain medical procedures (such as [[endosco ...y block the action of [[levodopa]] (used in the treatment of [[Parkinson's Disease]]).<ref name="Holt" />
    78 KB (10,295 words) - 16:51, 27 September 2010
  • ...are potentially pro-arrhythmic, especially in settings of structural heart disease (e.g. post-[[myocardial infarction]]), and are contraindicated in such sett ...channel blocker with potential clinical efficacy for cystic fibrosis lung disease |journal=J. Pharmacol. Exp. Ther. |volume=325 |issue=1 |pages=77–88 |year
    8 KB (1,123 words) - 09:45, 20 September 2010
  • ...usto, Nelson|title = Anemia|work = Robbins and Cotran: Pathologic Basis of Disease, 7th edition|publisher = Elsevier Saunders ...iency]] and have consulted a doctor. Hemochromatosis is estimated to cause disease in between 0.3 and 0.8% of Caucasians.<ref>{{cite journal|title=Hereditary
    67 KB (9,808 words) - 10:24, 20 September 2010
  • {{Infobox Disease|Name=Carbon monoxide poisoning|Image=Carbon-monoxide-3D-vdW.png|Caption=Spa ...[[cardiovascular disease]], [[cardiac output]], [[anemia]], [[sickle cell disease]] and other hematological disorders, [[barometric pressure]], and [[metabol
    71 KB (9,723 words) - 21:31, 20 September 2010
  • ...between heavy exposures to manganese in mines with a form of [[Parkinson's Disease]].<ref>{{cite journal|last = Couper|first = J.|title = On the effects of bl ...of pathophysiologic mechanisms.|issue = 4}}</ref> similar to [[Parkinson's Disease]] called "[[manganism]]" has been linked to manganese exposure amongst mine
    44 KB (6,128 words) - 21:32, 20 September 2010
  • ...oxygen-binding capacity of haemoglobin in patients with severe respiratory disease |journal=Br J Anaesth |volume=53 |issue=12 |pages=1325–8 |year=1981 |mont ...own hemoglobinopathy is [[sickle-cell disease]], which was the first human disease whose [[mechanism (biology)|mechanism]] was understood at the molecular lev
    67 KB (9,844 words) - 20:17, 21 September 2010
  • ...sign]] || [[Jean Marie Charles Abadie]] ||endocrinology ||[[Graves' disease]] || ||levator palpebrae superioris spasm | A || [[Abelin reaction]] || [[Isaak Abelin]] ||infectious disease ||[[syphilis]] || ||presence of arsenical anti-syphilitic;obsolete
    59 KB (6,670 words) - 21:04, 21 September 2010
  • | [[Alzheimer's Disease]] | [[Adult Refsum disease]]
    19 KB (2,282 words) - 21:04, 21 September 2010
  • * [[Lev's disease]] (Lenegre-Lev syndrome) ==Congenital heart disease==
    5 KB (536 words) - 21:05, 21 September 2010
  • ...ral sclerosis|Lou Gehrig's disease]], [[Hartnup disease]] and [[Mortimer's disease]]). ...ver]], [[Brooklyn eye]]) and even societies ([[Legionellosis|Legionnaires' disease]]). These, however, are not eponyms.
    29 KB (3,290 words) - 21:05, 21 September 2010
  • *'''parkinsonian'''—[[James Parkinson]] (as in ''[[Parkinson's disease|parkinsonian syndrome]]'')
    27 KB (3,426 words) - 21:05, 21 September 2010
  • * [[Pierre Marie]] — [[Charcot-Marie-Tooth disease]] * [[Prosper Ménière]] — [[Ménière's disease]]
    29 KB (3,507 words) - 21:06, 21 September 2010
  • A list of [[disease]]s in the English wikipedia. * [[Wagner's disease]]
    4 KB (376 words) - 21:07, 21 September 2010
  • A list of [[disease]]s in the English Wikipedia. * [[Paget disease extramammary]]
    22 KB (1,911 words) - 21:07, 21 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)